CALU抗体,Rabbit Polyclonal CALU Antibody
  • CALU抗体,Rabbit Polyclonal CALU Antibody
  • CALU抗体,Rabbit Polyclonal CALU Antibody
  • CALU抗体,Rabbit Polyclonal CALU Antibody

CALU抗体

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 湖北
更新日期 2025-05-11
QQ交谈 微信洽谈

产品详情

中文名称:CALU抗体英文名称:Rabbit Polyclonal CALU Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 1872 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: CALU
2025-05-11 CALU抗体 Rabbit Polyclonal CALU Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 1872 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/100-1/300 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/10000 Human,Mouse,Rat
   

产品详情

Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human CALU
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human gasrtic cancer tissue using P01149(CALU Antibody) at dilution 1/40. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P01149(CALU Antibody) at dilution 1/40. (Original magnification: ×200)    


           

参考文献

以下是我模拟生成的关于CALU(Calumenin)抗体的参考文献示例,供参考使用(注:以下内容为虚构,实际文献请通过学术数据库查询):

---

1. **文献名称**:*Calumenin as a Novel Biomarker in Colorectal Cancer: Diagnostic Potential of Anti-Calumenin Antibodies*

**作者**:Li, X.; Wang, H.; Zhang, Y.

**摘要**:本研究通过免疫组化分析,发现Calumenin在结直肠癌组织中高表达,并开发了特异性CALU抗体用于检测。结果显示,Calumenin表达水平与肿瘤转移呈正相关,提示其可能作为诊断标志物及治疗靶点。

2. **文献名称**:*Role of Calumenin in Vascular Smooth Muscle Cell Calcification: Insights from Antibody-Based Inhibition Studies*

**作者**:Johnson, R.K.; Müller, S.

**摘要**:利用CALU抗体阻断实验,证明Calumenin通过调节细胞内钙稳态参与血管平滑肌细胞钙化过程,为动脉粥样硬化的机制研究提供了新方向。

3. **文献名称**:*Anti-Calumenin Autoantibodies in Autoimmune Diseases: Correlation with Disease Activity*

**作者**:Chen, L.; Tanaka, M.; Rossi, F.

**摘要**:首次在系统性红斑狼疮(SLE)患者血清中检测到抗Calumenin自身抗体,其滴度与疾病活动度显著相关,提示CALU抗体可能参与自身免疫病理过程。

---

**建议**:实际研究中,请通过**PubMed**或**Google Scholar**以关键词“Calumenin antibody”、“Calumenin biomarker”等检索最新文献,或查阅以下领域期刊:

- *Journal of Cellular Biochemistry*

- *Clinical and Experimental Immunology*

- *Cardiovascular Research*

       

背景信息

CALU (Calumenin) antibodies target a protein belonging to the CREC family, which is involved in calcium-binding and regulation within the endoplasmic reticulum (ER). Calumenin, encoded by the *CALU* gene, plays roles in modulating calcium-dependent processes, protein folding, and quality control in the ER. It interacts with other ER-resident chaperones, such as calreticulin and protein disulfide isomerase, influencing secretory pathway functions.

CALU antibodies are widely used in research to study its expression, localization, and functional roles in physiological and pathological contexts. Dysregulation of calumenin has been linked to cardiovascular diseases, cancer, and neurodegenerative disorders. For instance, altered calumenin levels are observed in atrial fibrillation, where calcium signaling is disrupted, and in certain cancers, where it may affect drug resistance or metastasis.

These antibodies enable detection via techniques like Western blotting, immunohistochemistry, and immunofluorescence, aiding investigations into ER stress, calcium homeostasis, and cellular responses to oxidative damage. Recent studies also explore calumenin's potential as a biomarker or therapeutic target, emphasizing its regulatory interplay with other calcium-handling proteins. Research using CALU antibodies continues to uncover its multifaceted roles in cellular physiology and disease mechanisms.

       
关键字: CALU抗体;CALU;CALU Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。
成立日期 2024-06-24 (2年) 注册资本 50万(元)
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 中间体,化学试剂 经营模式 贸易,工厂,试剂,定制,服务
  • 湖北瑞和宁生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:50万(元)
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:中间体。试剂
  • 公司地址:江汉区
询盘

店内推荐

CALU抗体相关厂家报价

产品名称 价格   公司名称 报价日期
¥1600.00
VIP10年
北京索莱宝科技有限公司
2026-02-10
询价
VIP4年
吉奥蓝图(广东)生命科学技术中心
2026-02-12
询价
广州弗尔博生物科技有限公司
2026-01-07
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.